Cytotoxicity effect of graphene oxide on human MDA-MB-231 cells

Toxicology Mechanisms and Methods

Volumn 25, Issue 4, 2015, Pages 312-319

  Wu, Jing ^a   Yang, Rui ^b   Zhang, Lei ^a   Fan, Zhijuan ^a   Liu, Shuye ^a  

^a Tianjin Third Central Hospital Jintang Road   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; mechanism; oxidative stress; toxicity

Indexed keywords

GRAPHENE OXIDE; KI 67 ANTIGEN; LACTATE DEHYDROGENASE; NANOSHEET; REACTIVE OXYGEN METABOLITE; GRAPHITE; NANOMATERIAL; OXIDE;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; ENZYME RELEASE; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL SURVIVAL; DRUG EFFECTS; FEMALE; METABOLISM; STEM CELL; TUMOR CELL LINE; TUMOR STEM CELL ASSAY;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; G0 PHASE; G1 PHASE; GRAPHITE; HUMANS; L-LACTATE DEHYDROGENASE; NANOSTRUCTURES; OXIDES; REACTIVE OXYGEN SPECIES; STEM CELLS; TUMOR STEM CELL ASSAY;

EID: 84940544129     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2015.1031415     Document Type: Article

References (47)

1. AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. (2009). Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3:279-90.
2. Balandin AA, Ghosh S, Bao W, et al. (2008). Superior thermal conductivity of single-layer graphene. Nano Lett 9:902-7.
3. Bao H, Pan Y, Ping Y, et al. (2011). Chitosan-functionalized grapheme oxide as a nanocarrier for drug and gene delivery. Small 7:1569-78.
4. Becerril HA, Mao J, Liu Z, et al. (2008). Evaluation of solutionprocessed reduced graphene oxide films as transparent conductors. ACS Nano 2:463-70.
5. Bhattacharya K, Hoffmann E, Schins RF, et al. (2012). Comparison of micro-and nano-scale Fe+3-containing (Hematite) particles for their toxicological properties in human lung cells. In Vitro Toxicol Sci 126: 173-82.
6. Chang Y, Yang ST, Liu JH, et al. (2011). In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicol Lett 200:201-10.
7. Chen GY, Meng CL, Lin KC, et al. (2014). Graphene oxide as a chemosensitizer: diverted autophagic flux, enhanced nuclear import, elevated necrosis and improved antitumor effects. Biomaterials 40:12-22.
8. Chen WH, Lecaros RL, Tseng YC, et al. (2015). Nanoparticle delivery of HIF1a siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer. Cancer Lett 359:65-74.
9. Cheng HB, Bo Y, Shen WX, et al. (2015). Longikaurin E induces apoptosis of pancreatic cancer cells via modulation of the p38 and PI3K/AKT pathways by ROS. Naunyn Schmiedebergs Arch Pharmacol. [Epub ahead of print].
10. Ding Z, Zhang Z, Ma H, Chen Y. (2014). In vitro hemocompatibility and toxic mechanism of graphene oxide on human peripheral blood T lymphocytes and serum albumin. ACS Appl Mater Interfaces 6: 19797-807.
11. Dreyer DR, Park S, Bielawski CW, Ruoff RS. (2010). The chemistry of graphene oxide. Chem Soc Rev 39:228-40.
12. Du L, Wu S, Li Y, et al. (2014). Cytotoxicity of PEGylated graphene oxide on lymphoma cells. Biomed Mater Eng 24: 2135-41.
13. Endl E, Steinbach P, Knüchel R, Hofstädter F. (1997). Analysis of cell cycle-related Ki-67 and p120 expression by flow cytometric BrdUrd-Hoechst/7 AAD and immunolabeling technique. Cytometry 29: 233-41.
14. Esch RK, Han L, Foarde KK, Ensor DS. (2010). Endotoxin contamination of engineered nanomaterials. Nanotoxicology 4:73-83.
15. Geim AK. (2009). Graphene: status and prospects. Science 324:1530-4.
16. Geim AK, Novoselov KS. (2007). The rise of graphene. Nat Mater 6: 183-91.
17. Gharagozloo M, Majewski S, Foldvari M. (2015). Therapeutic applications of nanomedicine in autoimmune diseases: from immunosuppression to tolerance induction. Nanomedicine. [Epub ahead of print]. doi: 10.1016/j.nano.2014.12.003.
18. Guo X, Mei N. (2014). Assessment of the toxic potential of graphene family nanomaterials. J Food Drug Anal 22:105-15.
19. Huang Y, Liang J, Chen Y. (2012). An overview of the applications of graphene-based materials in supercapacitors. Small 8:1805-34.
20. Kim JS, Yu IJ. (2014). Single-wall carbon nanotubes (SWCNT) induce cytotoxicity and genotoxicity produced by reactive oxygen species (ROS) generation in phytohemagglutinin (PHA)-stimulated male human peripheral blood lymphocytes. J Toxicol Environ Health A 77:1141-53.
21. Lee C, Wei X, Kysar JW, Hone J. (2008). Measurement of the elastic properties and intrinsic strength of monolayer graphene. Science 321: 385-8.
22. Liao KH, Lin YS, Macosko CW, Haynes CL. (2011). Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. ACS Appl Mater Interfaces 3:2607-15.
23. Liu Z, Robinson JT, Sun X, Dai H. (2008). PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc 130:10876-7.
24. Lu WB, Liu S, Qin XY, et al. (2012). High-yield, large-scale production of few-layer graphene flakes within seconds: using chlorosulfonic acid and H2O2 as exfoliating agents. J Mater Chem 22:8775-7.
25. Lv M, Zhang Y, Liang L, et al. (2012). Effect of graphene oxide on undifferentiated and retinoic acid-differentiated SH-SY5Y cells line. Nanoscale 4:3861-6.
26. Makharza S, Vittorio O, Cirillo G, et al. (2014). Graphene oxide-Gelatin nanohybrids as functional tools for enhanced carboplatin activity in neuroblastoma cells. Pharm Res. [Epub ahead of print].
27. Markovic ZM, Harhaji-Trajkovic LM, Todorovic-Markovic BM, et al. (2011). In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes. Biomaterials 32: 1121-9.
28. Nanda SS, An SS, Yi DK. (2015). Oxidative stress and antibacterial properties of a graphene oxide-cystamine nanohybrid. Int J Nanomedicine 10:549-56.
29. Novoselov KS, Geim AK, Morozov SV, et al. (2004). Electric field effect in atomically thin carbon films. Science 306:666-9.
30. Preusser M, Heinzl H, Gelpi E, et al. (2008). Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker. Histopathology 53:39-47.
31. Saeed LM, Mahmood M, Pyrek SJ, et al. (2014). Single-walled carbon nanotube and graphene nanodelivery of gambogic acid increases its cytotoxicity in breast and pancreatic cancer cells. J. Appl. Toxicol. 34: 1188-99.
32. Sohaebuddin SK, Thevenot PT, Baker D, et al. (2010). Nanomaterial cytotoxicity is composition, size, and cell type dependent. Part Fibre Toxicol 21:22.
33. Sun X, Liu Z, Welsher K, et al. (2008). Nano-graphene oxide for cellular imaging and drug delivery. Nano Res 1:203-12.
34. Tung VC, Allen MJ, Yang Y, Kaner RB. (2009). High-throughput solution processing of large-scale graphene. Nat Nanotechnol 4:25-9.
35. Wang K, Ruan J, Song H, et al. (2011). Biocompatibility of graphene oxide. Nanoscale Res Lett 6:8.
36. Wu J, Wang YS, Yang XY, et al. (2012). Graphene oxide used as a carrier for adriamycin can reverse drug resistance in breast cancer cells. Nanotechnology 23:355101.
37. Xu H, Li X, Ding W, et al. (2015a). Deguelin induces the apoptosis of lung cancer cells through regulating a ROS driven Akt pathway. Cancer Cell Int 25:15-25.
38. Xu Y, Wang Z, Wang J, et al. (2010). Lentivirus-mediated knockdown of cyclin Y (CCNY) inhibits glioma cell proliferation. Oncol Res 18: 359-64.
39. Xu Z, Zhu S, Wang M, et al. (2015b). Delivery of paclitaxel using PEGylated graphene oxide as a nanocarrier. ACS Appl Mater Interfaces 7:1355-63.
40. Yang K, Zhang S, Zhang G, et al. (2010). Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett 10:3318-23.
41. Yang K, Wan J, Zhang S, et al. (2011). In vivo pharmacokinetics, longterm biodistribution and toxicology of PEGylated graphene in mice. ACS Nano 5:516-22.
42. Yang M, Zhang M, Tahara Y, et al. (2014). Lysosomal membrane permeabilization: carbon nanohorn-induced reactive oxygen species generation and toxicity by this neglected mechanism. Toxicol Appl Pharmacol 280:117-26.
43. Yang XY, Zhang XY, Liu ZF, et al. (2008). High-efficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide. J Phys Chem C 112:17554-8.
44. Zhang XY, Yin JL, Peng C, et al. (2011). Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration. Carbon 49:986-95.
45. Zhang Y, Ali SF, Dervishi E, et al. (2010). Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano 4: 3181-6.
46. Zhao X, Yang L, Li X, et al. (2015). Functionalized graphene oxide nanoparticles for cancer cell-specific delivery of antitumor drug. Bioconjug Chem 26:128-36.
47. Zhou T, Zhang B, Wei P, et al. (2014). Energy metabolism analysis reveals the mechanism of inhibition of breast cancer cell metastasis by PEG-modified graphene oxide nanosheets. Biomaterials 35:9833-43.